Mounjaro Side Effects: Common, Serious and How They're Managed

The most common side effects of Mounjaro (tirzepatide) are digestive: nausea, diarrhoea, constipation, vomiting, indigestion and reduced appetite. They tend to be mild to moderate, most noticeable when you first start and in the days after each dose increase, and they often ease as your body adjusts. Serious side effects, such as pancreatitis and gallbladder problems, are much less common but important to recognise. Most side effects can be managed with practical changes to eating habits and by adjusting the pace of dose increases, a decision that rests with your prescriber.

This guide sets out what the clinical trials and the UK product information show, why side effects happen, how they are usually managed and which symptoms need urgent attention. For an overview of the medicine itself, see our complete guide to Mounjaro in the UK or visit the Mounjaro hub.

Why Mounjaro causes side effects

Tirzepatide activates GLP-1 and GIP receptors, mimicking gut hormones that regulate appetite and digestion. Two of its main actions explain most side effects:

• It slows stomach emptying. Food stays in the stomach longer, which helps you feel full but can also cause nausea, bloating, burping and reflux, especially after large or rich meals.
• It acts on brain areas involved in appetite and nausea. This reduces hunger, but the same pathways are involved in feelings of sickness.

Because these effects are strongest when the body first meets a new, higher dose, side effects cluster around the start of treatment and each dose step. That is why the dose is increased gradually, starting at 2.5mg. See How Mounjaro works for the full explanation.

How common are the side effects?

The most detailed data come from SURMOUNT-1, a 72-week trial of 2,539 adults with obesity or overweight without diabetes, published in the New England Journal of Medicine in 2022. The table shows approximate rates of the main digestive side effects.

Approximate figures from the SURMOUNT-1 publication; ranges reflect the different dose groups. Rates in everyday use may differ.

Three patterns stand out. Side effects were more common at higher doses, they were mostly mild to moderate, and they occurred mainly during the dose-escalation period. Most people who experienced them continued treatment.

Side effects listed in the UK product information

The Mounjaro Summary of Product Characteristics (SmPC) groups side effects by how often they occur. For weight management, the categories broadly include:

• Very common (may affect more than 1 in 10 people): nausea, diarrhoea, constipation, vomiting, abdominal pain
• Common (up to 1 in 10): reduced appetite, indigestion, bloating, burping, wind, reflux, dizziness, tiredness, hair loss, injection-site reactions, low blood pressure, a faster heart rate, raised pancreatic enzymes on blood tests, and hypersensitivity reactions
• Uncommon (up to 1 in 100): gallstones, gallbladder inflammation, acute pancreatitis, changes in taste

Low blood sugar is listed as very common in people with type 2 diabetes who also take insulin or a sulfonylurea. Always check the patient information leaflet supplied with your pen for the current, complete list, as product information is updated over time.

How long side effects usually last

Most digestive side effects follow a recognisable pattern. The table below describes what is commonly reported; it is a general guide rather than a prediction for any individual.

In SURMOUNT-1, the proportion of participants reporting nausea, diarrhoea and vomiting was highest during the dose-escalation weeks and fell afterwards. If side effects are getting worse rather than better over time, or are new after a long period on a stable dose, it is worth discussing them with your prescriber, because other causes may need to be considered.

Who may be more likely to have side effects?

Some factors are commonly associated with a higher chance of troublesome digestive effects:

• Higher doses and faster increases. Side effects were more frequent at higher doses in the trials.
• Large or high-fat meals. Because food stays in the stomach longer, rich meals are more likely to cause nausea, reflux and sulphurous burps.
• Existing digestive conditions. People with reflux, irritable bowel syndrome or previous gallbladder problems may notice symptoms more.
• Low fluid intake. Dehydration can worsen constipation, dizziness and tiredness.
• Alcohol. Alcohol can irritate the stomach and add to nausea and dehydration. See Mounjaro and alcohol.

None of these necessarily means Mounjaro is unsuitable, but they are worth mentioning to your prescriber at the start.

Common side effects and how they are managed

The advice below reflects commonly recommended self-care strategies. It does not replace advice from your own prescriber or pharmacist.

Nausea

Nausea is the single most frequently reported side effect. It is usually worst a day or two after the injection and in the first few weeks at each new dose.

Commonly suggested approaches include:

• eating smaller meals more often and stopping as soon as you feel full
• eating slowly and chewing well
• avoiding greasy, fried, very rich or very sugary foods
• choosing bland, plain foods when nausea is bad
• sipping fluids through the day rather than drinking large amounts at once
• not lying down straight after eating
• getting fresh air, or trying ginger or peppermint, which some people find soothing

If nausea is persistent, your prescriber may recommend staying at your current dose for longer before increasing, or in some cases returning to a lower dose. Some prescribers suggest anti-sickness medicine for short periods. Our guide to managing nausea on GLP-1 medication goes into more detail, and the Mounjaro nausea page summarises the key points.

Diarrhoea

Diarrhoea is common, particularly early in treatment. The main concern is dehydration, especially if it occurs alongside vomiting or reduced drinking.

• Drink plenty of fluids, and consider oral rehydration solutions if diarrhoea is frequent.
• Limit fatty, spicy and very high-sugar foods, and sweeteners such as sorbitol.
• Be aware that diarrhoea or vomiting may reduce how well the contraceptive pill works.

See our guide to diarrhoea on GLP-1 medication.

Constipation

Constipation is common partly because the gut slows and partly because people eat and drink less overall.

• Aim to drink enough fluids through the day.
• Include fibre from vegetables, fruit, pulses and wholegrains, increasing gradually.
• Keep active, as movement helps bowel function.
• Ask a pharmacist about laxatives if lifestyle changes are not enough.

See our guide to constipation on GLP-1 medication.

Vomiting

Occasional vomiting is not unusual, often after eating too much or too fast. Repeated vomiting is more concerning because it can cause dehydration and may signal a more serious problem. Contact your prescriber if you cannot keep fluids down, and seek urgent help if vomiting comes with severe abdominal pain.

Indigestion, reflux and burping

Slower stomach emptying can cause heartburn, acid reflux and burping, sometimes with an eggy or sulphurous smell. Smaller meals, avoiding eating late at night, limiting fizzy drinks and fatty food, and raising the head of the bed can help. A pharmacist can advise on antacids. See burping, reflux and indigestion on GLP-1 medication.

Reduced appetite and tiredness

Reduced appetite is how the medicine works, but eating too little can leave you tired, light-headed or short of nutrients. Focusing on protein, fruit, vegetables and fluids at each meal helps. Our guide on what to eat on GLP-1 medication offers practical ideas.

Injection-site reactions

Redness, itching, bruising or mild swelling at the injection site can occur. Rotating sites each week, letting the skin dry after cleaning and using a new needle every time can help. See our KwikPen guide for technique tips.

Hair loss

Some people notice increased hair shedding a few months into treatment. This is often attributed to telogen effluvium, a temporary shedding that can follow rapid weight loss or physical stress, and it usually improves. See Mounjaro and hair loss.

Serious side effects

These are less common, but recognising them early matters.

Acute pancreatitis

Inflammation of the pancreas has been reported with tirzepatide and other GLP-1-based medicines. The SmPC lists it as uncommon. Typical symptoms are severe, persistent pain in the upper abdomen that may spread to the back, often with nausea and vomiting. If you suspect pancreatitis, stop Mounjaro and seek urgent medical help. Tell your prescriber before starting if you have ever had pancreatitis. In 2025 the MHRA launched a Yellow Card Biobank project to investigate whether genetic factors make some people more susceptible. See GLP-1 medication and pancreatitis.

Gallbladder problems

Gallstones and gallbladder inflammation (cholecystitis) are more likely during rapid weight loss, whatever the cause. Symptoms include pain in the upper right abdomen, which may spread to the right shoulder, fever, and yellowing of the skin or eyes. See GLP-1 medication and gallbladder problems.

Dehydration and kidney problems

Severe or prolonged vomiting and diarrhoea can cause dehydration, which in turn can lead to a sudden decline in kidney function. People with existing kidney problems should be monitored carefully. Signs of significant dehydration include dark urine or passing very little, dizziness, and confusion.

Low blood sugar (hypoglycaemia)

Tirzepatide alone rarely causes low blood sugar in people without diabetes. The risk increases significantly in people with type 2 diabetes who also take insulin or a sulfonylurea such as gliclazide, and their doses may need reducing. Symptoms include shakiness, sweating, hunger, a fast heartbeat and confusion.

Allergic reactions

Serious allergic reactions are rare but possible. Swelling of the face, lips, tongue or throat, difficulty breathing or a widespread rash need emergency care.

Aspiration during anaesthesia

In 2025 the MHRA highlighted, in a Drug Safety Update, the potential risk of pulmonary aspiration (stomach contents entering the lungs) during general anaesthesia or deep sedation in people taking GLP-1 and dual GIP/GLP-1 medicines, because the stomach may not empty normally. Always tell the surgical or endoscopy team you are taking Mounjaro. See GLP-1 medication before surgery and anaesthesia.

Diabetic eye disease

In people with type 2 diabetes and existing diabetic retinopathy, rapid improvements in blood sugar have been associated with temporary worsening of eye disease. People with diabetes should keep up with retinal screening and report changes in vision.

Side effects that need particular thought

Contraception and pregnancy

Mounjaro may reduce how well oral contraceptives are absorbed. The SmPC advises women using oral contraceptives to consider switching to a non-oral method, or adding a barrier method, for four weeks after starting and for four weeks after each dose increase. Mounjaro should not be used during pregnancy, and the SmPC advises stopping at least one month before a planned pregnancy. The MHRA reinforced this advice in 2025. See Mounjaro, GLP-1s and contraception.

Mental health

There have been reports of mood changes and suicidal thoughts in people taking GLP-1-based medicines. The European Medicines Agency's review in 2024 did not find evidence of a causal link, and regulators continue to monitor reports. People with a history of depression, anxiety or eating disorders should discuss this with their prescriber. See GLP-1 medication and mental health.

Muscle loss

Some of the weight lost on any significant weight-loss treatment comes from lean tissue, including muscle. This is not a side effect in the usual sense, but it is relevant to long-term health, especially in older adults. Protein intake and resistance exercise are commonly advised. See preserving muscle mass on GLP-1 treatment.

How prescribers adjust treatment for side effects

Prescribers have several options when side effects are troublesome. These decisions should be made by them, not by adjusting doses yourself:

The licence allows for maintenance at 5mg, 10mg or 15mg, so not everyone needs the highest dose. See Mounjaro doses explained.

Mounjaro compared with Wegovy on side effects

Side-effect profiles of tirzepatide and semaglutide are broadly similar, with digestive effects dominating for both. In the SURMOUNT-5 trial, which compared them head to head in adults with obesity, rates of digestive side effects were similar between the two groups, and most were mild to moderate. Individual experiences differ, and some people tolerate one better than the other. See Mounjaro vs Wegovy for a broader comparison.

Questions to ask your prescriber about side effects

Having a short list of questions can make reviews more useful. You might ask:

• Which side effects should I expect at my current dose, and how long are they likely to last?
• What should I do if I cannot keep food or fluids down?
• Should I delay my next dose increase if I am still having nausea?
• Are any of my other medicines likely to interact with Mounjaro or need adjusting?
• What contraception should I use, and for how long after each dose increase?
• Who do I contact out of hours if I am worried?

Keeping a simple diary of side effects, including when they start in relation to your injection and what you had eaten, can help your prescriber decide whether to hold, reduce or continue your dose.

Getting help from your provider

A regulated provider, whether NHS or private, should offer a clear way to report side effects and get clinical advice between supplies. When comparing services, it is worth checking how easily you can reach a pharmacist or prescriber and how follow-up works. Our providers page compares services on these points, and our prices page explains what affects the cost of ongoing support.

You can report suspected side effects directly to the MHRA through the Yellow Card scheme, online or via the Yellow Card app. Reports help regulators identify new safety signals.

When to speak to a professional

Contact your GP, pharmacist or prescriber if:

• nausea, vomiting, diarrhoea or constipation lasts more than a few days or is affecting daily life
• you cannot eat or drink enough to stay hydrated
• you have diabetes and notice symptoms of low blood sugar
• you notice persistent hair loss, low mood, changes in vision or anything else that worries you
• you are planning a pregnancy, think you may be pregnant or have questions about contraception
• you are due to have surgery or a procedure under sedation or anaesthetic

Stop taking Mounjaro and seek urgent medical help (NHS 111, A&E, or 999 in an emergency) if you have:

• severe, persistent abdominal pain, especially if it spreads to your back, with or without vomiting
• pain in the upper right abdomen with fever, or yellowing of the skin or the whites of the eyes
• vomiting that will not stop, or signs of severe dehydration such as very little urine, dizziness or confusion
• swelling of the face, lips, tongue or throat, difficulty breathing or a widespread rash